These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6258517)

  • 1. Loss of susceptibility to antibody and complement mediated lysis in E. histolytica.
    Calderon J; Tovar-Gallegos R
    Arch Invest Med (Mex); 1980; 11(1 Suppl):241-4. PubMed ID: 6258517
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of susceptibility to complement lysis in Entamoeba histolytica HM1 by treatment with human serum.
    Calderon J; Tovar R
    Immunology; 1986 Jul; 58(3):467-71. PubMed ID: 2874111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-surface antibodies to Entamoeba histolytica and their role in complement lysis.
    Trissl D; Müller R; Ries R; Rathmann M
    Arch Invest Med (Mex); 1986; 17 Suppl 1():203-8. PubMed ID: 2884957
    [No Abstract]   [Full Text] [Related]  

  • 4. Complement sensitivity of Entamoeba histolytica and various nonpathogenic amoeba species.
    Förster B; Ebert F; Horstmann RD
    Trop Med Parasitol; 1994 Dec; 45(4):355-6. PubMed ID: 7716404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanism of acquired resistance to complement-mediated lysis by Entamoeba histolytica.
    Gutiérrez-Kobeh L; Cabrera N; Pérez-Montfort R
    J Parasitol; 1997 Apr; 83(2):234-41. PubMed ID: 9105303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence of Entamoeba histolytica correlates with the capacity to develop complement resistance.
    Mogyoros M; Calef E; Gitler C
    Isr J Med Sci; 1986 Dec; 22(12):915-7. PubMed ID: 2883155
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum proteins in the plasma membrane of Entamoeba histolytica.
    Noya González O; Warren LG; Gohd R
    Arch Invest Med (Mex); 1980; 11(1 Suppl):109-14. PubMed ID: 6258504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultramicroscopy of the membranolysis of E. histolytica induced by immune serum].
    Treviño-García Manzo N; Castañeda M; Chévez A
    Arch Invest Med (Mex); 1974; 5 SUPPL 2():325-30. PubMed ID: 4376916
    [No Abstract]   [Full Text] [Related]  

  • 9. [Entamoeba histolytica: II. Effect of humoral immune mechanisms on cytotoxic activity].
    Hudler H; Scheiner O; Stemberger H; Kollaritsch H; Wiedermann G
    Tropenmed Parasitol; 1984 Mar; 35(1):5-8. PubMed ID: 6324430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis of pathogenic and nonpathogenic Entamoeba histolytica by human complement: methodological analysis.
    Hamelmann C; Foerster B; Burchard GD; Horstmann RD
    Parasite Immunol; 1992 Jan; 14(1):23-35. PubMed ID: 1557228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-mediated killing of myeloma tumour cells: differences in susceptibility to lysis by antibodies and complement are independent of antigen expression and antibody binding.
    Celis B; Celis E
    Immunology; 1983 Jun; 49(2):321-8. PubMed ID: 6343234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entamoeba histolytica: monoclonal antibody against the beta1 integrin-like molecule (140 kDa) inhibits cell adhesion to extracellular matrix components.
    Sengupta K; Hernández-Ramírez VI; Rios A; Mondragón R; Talamás-Rohana P
    Exp Parasitol; 2001 Jun; 98(2):83-9. PubMed ID: 11465991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD59 (protectin) molecule, resistance to complement, and virulence of Entamoeba histolytica.
    Flores-Romo L; Tsutsumi V; Estrada-García T; Shibayama M; Aubry JP; Bacon KB; Martínez-Palomo A
    Trans R Soc Trop Med Hyg; 1994; 88(1):116-7. PubMed ID: 7512288
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of specific antibodies and complement on the motility and the viability of Entamoeba histolytica trophozoites.
    Aust Kettis A; Utter G
    Am J Trop Med Hyg; 1984 Jul; 33(4):569-77. PubMed ID: 6089600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysozyme and complement-dependent lysis of Entamoeba histolytica. Inhibition by leupeptin.
    Mogyoros M; Fishelson Z; Gitler C
    Isr J Med Sci; 1986 Dec; 22(12):918-20. PubMed ID: 2883156
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective effects of various compounds on lysis of antibody-coated sheep erythrocytes by hypotonic shock or complement.
    Müller-Peddinghaus R; Erdtmann K
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):287-92. PubMed ID: 6748820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A solid-phase sandwich radioimmunoassay for Entamoeba histolytica proteins and the detection of circulating antigens in amoebiasis.
    Pillai S; Mohimen A
    Gastroenterology; 1982 Dec; 83(6):1210-6. PubMed ID: 6290308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening and expression of recombinant human monoclonal antibody Fab fragments specific to Entamoeba histolytica].
    Shu Q; Sha HX; Tachibana H; Cheng XJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Apr; 22(2):65-9. PubMed ID: 15281441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcium binding protein of Entamoeba histolytica: expression in Escherichia coli and immunochemical characterization.
    Prasad J; Bhattacharya S; Bhattacharya A
    Cell Mol Biol Res; 1993; 39(2):167-75. PubMed ID: 8220585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis of sheep red cells in neat autologous serum as a source of antibody and complement.
    Borsos T; Circolo A
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():5-9. PubMed ID: 6587743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.